Carrick Therapeutics Lays Foundation For 'Leading Oncology Business'

03 Oct 2016

With $95m in the bank from various investors – including ARCH Ventures, Woodford Investment Management, Google Ventures and drug discovery company Evotec – recently launched Carrick Therapeutics is striving to be at the forefront of oncology companies in Europe.

Bricks — Carrick Therapeutics has built a 'solid foundation' for a leading European oncology company • Source: Shutterstock/Aleks Melnik

Carrick Therapeutics Lays Foundation For 'Leading Oncology Business'

More from Strategy

More from Business